164 related articles for article (PubMed ID: 37243488)
1. Pharmacokinetics of ampicillin during venovenous extracorporeal membrane oxygenation: A case report.
Kim S; Stucky NL; Drummond W; Elbarbry F; Footer BW
Pharmacotherapy; 2023 Aug; 43(8):864-868. PubMed ID: 37243488
[TBL] [Abstract][Full Text] [Related]
2. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
Hahn J; Min KL; Kang S; Yang S; Park MS; Wi J; Chang MJ
Microbiol Spectr; 2021 Dec; 9(3):e0063321. PubMed ID: 34937189
[TBL] [Abstract][Full Text] [Related]
3. Population Pharmacokinetics and Dosing Simulations of Ceftriaxone in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (An ASAP ECMO Study).
Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Cho YJ; Corley A; Gilder E; Kim HS; Lim SY; McGuinness S; Parke R; Reynolds C; Rudham S; Wallis SC; Welch SA; Fraser JF; Shekar K; Roberts JA;
Clin Pharmacokinet; 2022 Jun; 61(6):847-856. PubMed ID: 35253107
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of ciprofloxacin in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Corley A; Diehl A; Levkovich BJ; Pellegrino V; Reynolds C; Rudham S; Wallis SC; Welch SA; Roberts JA; Shekar K; Fraser JF;
Anaesth Crit Care Pain Med; 2022 Jun; 41(3):101080. PubMed ID: 35472580
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Corley A; Diehl A; Jakob SM; Levkovich BJ; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Roberts JA; Shekar K; Fraser JF
Int J Antimicrob Agents; 2021 Dec; 58(6):106466. PubMed ID: 34688834
[TBL] [Abstract][Full Text] [Related]
6. Influence of venovenous extracorporeal membrane oxygenation on pharmacokinetics of vancomycin in lung transplant recipients.
Liu D; Chen W; Wang Q; Li M; Zhang Z; Cui G; Li P; Zhang X; Ma Y; Zhan Q; Wang C
J Clin Pharm Ther; 2020 Oct; 45(5):1066-1075. PubMed ID: 32542736
[TBL] [Abstract][Full Text] [Related]
7. The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.
Shekar K; Fraser JF; Taccone FS; Welch S; Wallis SC; Mullany DV; Lipman J; Roberts JA;
Crit Care; 2014 Dec; 18(6):565. PubMed ID: 25636084
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics and pharmacodynamics of antibiotics in septic children treated with extracorporeal membrane oxygenation].
Zhang HX; Huang JT; Dong J; Gong TZ; Zhang KY; Lu XL; Guo SW
Zhonghua Er Ke Za Zhi; 2023 Jul; 61(7):631-636. PubMed ID: 37385807
[No Abstract] [Full Text] [Related]
9. Pharmacokinetics of continuous-infusion meropenem in a pediatric patient receiving extracorporeal life support.
Cies JJ; Moore WS; Dickerman MJ; Small C; Carella D; Chopra A; Parker J
Pharmacotherapy; 2014 Oct; 34(10):e175-9. PubMed ID: 25146254
[TBL] [Abstract][Full Text] [Related]
10. β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study.
Donadello K; Antonucci E; Cristallini S; Roberts JA; Beumier M; Scolletta S; Jacobs F; Rondelet B; de Backer D; Vincent JL; Taccone FS
Int J Antimicrob Agents; 2015 Mar; 45(3):278-82. PubMed ID: 25542059
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and Time above the MIC Exposure of Cefepime in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO).
Kois AK; Gluck JA; Nicolau DP; Kuti JL
Int J Antimicrob Agents; 2022 Jul; 60(1):106603. PubMed ID: 35577257
[TBL] [Abstract][Full Text] [Related]
12. Ceftriaxone Pharmacokinetics and Pharmacodynamics in 2 Pediatric Patients on Extracorporeal Membrane Oxygenation Therapy.
Cervantes FC; Mizuno T; Dong M; Tang P; Arbough T; Vinks AA; Kaplan JM; Tang Girdwood SC
Ther Drug Monit; 2023 Dec; 45(6):832-836. PubMed ID: 37725684
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature.
Sherwin J; Heath T; Watt K
Clin Ther; 2016 Sep; 38(9):1976-94. PubMed ID: 27553752
[TBL] [Abstract][Full Text] [Related]
14. Alveolar and serum concentrations of imipenem in two lung transplant recipients supported with extracorporeal membrane oxygenation.
Welsch C; Augustin P; Allyn J; Massias L; Montravers P; Allou N
Transpl Infect Dis; 2015 Feb; 17(1):103-5. PubMed ID: 25572932
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
Hahn J; Choi JH; Chang MJ
J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of linezolid for methicillin-resistant Staphylococcus aureus pneumonia in an adult receiving extracorporeal membrane oxygenation.
Nikolos P; Osorio J; Mohrien K; Rose C
Am J Health Syst Pharm; 2020 May; 77(11):877-881. PubMed ID: 32426841
[TBL] [Abstract][Full Text] [Related]
17. NONMEM population pharmacokinetics and Monte Carlo dosing simulations of imipenem in critically ill patients with life-threatening severe infections during support with or without extracorporeal membrane oxygenation in an intensive care unit.
Jaruratanasirikul S; Boonpeng A; Nawakitrangsan M; Samaeng M
Pharmacotherapy; 2021 Jul; 41(7):572-597. PubMed ID: 34080708
[TBL] [Abstract][Full Text] [Related]
18. Population Pharmacokinetics of Meropenem in Plasma and Subcutis from Patients on Extracorporeal Membrane Oxygenation Treatment.
Hanberg P; Öbrink-Hansen K; Thorsted A; Bue M; Tøttrup M; Friberg LE; Hardlei TF; Søballe K; Gjedsted J
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530848
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of meropenem in children with sepsis undergoing extracorporeal life support: A prospective observational study.
Wang Y; Li Z; Chen W; Yan G; Wang G; Lu G; Chen C
J Clin Pharm Ther; 2021 Jun; 46(3):754-761. PubMed ID: 33476064
[TBL] [Abstract][Full Text] [Related]
20. Predictors of insufficient peak amikacin concentration in critically ill patients on extracorporeal membrane oxygenation.
Touchard C; Aubry A; Eloy P; Bréchot N; Lebreton G; Franchineau G; Besset S; Hékimian G; Nieszkowska A; Leprince P; Luyt CE; Combes A; Schmidt M
Crit Care; 2018 Aug; 22(1):199. PubMed ID: 30121083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
